PF-2545920

CAS No. 1292799-56-4

PF-2545920( —— )

Catalog No. M11184 CAS No. 1292799-56-4

PF-2545920 is a potent and selective PDE10A inhibitor with IC50 of 0.37 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 205 In Stock
2MG 93 In Stock
5MG 192 In Stock
10MG 265 In Stock
25MG 432 In Stock
50MG 622 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PF-2545920
  • Note
    Research use only, not for human use.
  • Brief Description
    PF-2545920 is a potent and selective PDE10A inhibitor with IC50 of 0.37 nM.
  • Description
    PF-2545920 is a potent and selective PDE10A inhibitor with IC50 of 0.37 nM, with >1000-fold selectivity over the PDE.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE10A
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1292799-56-4
  • Formula Weight
    392.45
  • Molecular Formula
    C25H20N4O
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 79 mg/mL (201.29 mM); DMSO: 79 mg/mL (201.29 mM)
  • SMILES
    CN1C=C(C(=N1)C2=CC=C(C=C2)OCC3=NC4=CC=CC=C4C=C3)C5=CC=NC=C5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wilson JM, et al. Neuropharmacology. 2015 Dec;99:379-86.
molnova catalog
related products
  • ONO-8430506

    ONO-8430506 is an orally available, potent autotaxin (ATX)/ENPP2 inhibitor (IC90: 100 nM) that inhibits ATX activity in mouse plasma.

  • LJI308

    LJI308 is a potent, and pan-RSK (p90 ribosomal S6 kinase) inhibitor with IC50 of 6 nM, 4 nM, and 13 nM for RSK1, RSK2, and RSK3, respectively.

  • PDE5-IN-9

    PDE5-IN-9 inhibits Phosphodiesterase PDE1c and is used to treat hypertension, heart failure, myocardial infarction, kidney failure, asthma, bronchitis, and dementia.